vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · Real-Time Price · USD
14.83
-0.82 (-5.24%)
Nov 21, 2024, 4:00 PM EST - Market closed

vTv Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
--20.25-19.16-12.99-8.5-13.04
Upgrade
Depreciation & Amortization
-0.090.090.090.090.04
Upgrade
Other Amortization
----0.380.53
Upgrade
Loss (Gain) From Sale of Assets
------0.29
Upgrade
Loss (Gain) From Sale of Investments
-1.183.59-2.45-4.25-
Upgrade
Stock-Based Compensation
-1.581.272.361.011.52
Upgrade
Other Operating Activities
--6.08-7.19-6.35-4.03-9.72
Upgrade
Change in Accounts Receivable
-0.07-0.120.1-0.15-0.01
Upgrade
Change in Accounts Payable
-2.93-0.861.83-1-0.62
Upgrade
Change in Unearned Revenue
--6.76-1.01-0.02-1.76
Upgrade
Change in Other Net Operating Assets
-1.39-0.4-0.89-1.530.32
Upgrade
Operating Cash Flow
--19.08-16.02-19.31-18-23.02
Upgrade
Capital Expenditures
---0.02---0.07
Upgrade
Sale of Property, Plant & Equipment
-----0.31
Upgrade
Investment in Securities
-4.4----
Upgrade
Investing Cash Flow
-4.4-0.02--0.24
Upgrade
Long-Term Debt Issued
-0.570.780.890.50.5
Upgrade
Long-Term Debt Repaid
--0.6-0.81-0.72-5.46-10.57
Upgrade
Net Debt Issued (Repaid)
--0.03-0.030.17-4.96-10.07
Upgrade
Issuance of Common Stock
-12.0314.7926.824.4332.94
Upgrade
Financing Cash Flow
-1214.7526.9819.4722.87
Upgrade
Net Cash Flow
--2.68-1.297.671.470.09
Upgrade
Free Cash Flow
--19.08-16.04-19.31-18-23.09
Upgrade
Free Cash Flow Margin
---795.00%-482.10%-280.64%-835.31%
Upgrade
Free Cash Flow Per Share
--9.15-8.36-12.33-15.27-30.49
Upgrade
Cash Interest Paid
-0.010.020.010.621.3
Upgrade
Cash Income Tax Paid
--0.20.12-0.1
Upgrade
Levered Free Cash Flow
-2.46-26.33-9.2-7.59-14.68
Upgrade
Unlevered Free Cash Flow
-2.47-26.32-9.2-7.54-14.07
Upgrade
Change in Net Working Capital
2.82-16.7413.58-0.91.232.5
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.